BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 25777797)

  • 1. miRNA in situ hybridization in circulating tumor cells--MishCTC.
    Ortega FG; Lorente JA; Garcia Puche JL; Ruiz MP; Sanchez-Martin RM; de Miguel-Pérez D; Diaz-Mochon JJ; Serrano MJ
    Sci Rep; 2015 Mar; 5():9207. PubMed ID: 25777797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classification of circulating tumor cells by epithelial-mesenchymal transition markers.
    Wu S; Liu S; Liu Z; Huang J; Pu X; Li J; Yang D; Deng H; Yang N; Xu J
    PLoS One; 2015; 10(4):e0123976. PubMed ID: 25909322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P-Akt/miR‑200 signaling regulates epithelial-mesenchymal transition, migration and invasion in circulating gastric tumor cells.
    Yuan D; Xia H; Zhang Y; Chen L; Leng W; Chen T; Chen Q; Tang Q; Mo X; Liu M; Bi F
    Int J Oncol; 2014 Dec; 45(6):2430-8. PubMed ID: 25200917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of circulating tumor cells harboring a unique ALK rearrangement in ALK-positive non-small-cell lung cancer.
    Pailler E; Adam J; Barthélémy A; Oulhen M; Auger N; Valent A; Borget I; Planchard D; Taylor M; André F; Soria JC; Vielh P; Besse B; Farace F
    J Clin Oncol; 2013 Jun; 31(18):2273-81. PubMed ID: 23669222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of epithelial-mesenchymal transitioned circulating tumor cells in patients with resectable gastric cancer: Relevance to therapy response.
    Li TT; Liu H; Li FP; Hu YF; Mou TY; Lin T; Yu J; Zheng L; Li GX
    World J Gastroenterol; 2015 Dec; 21(47):13259-67. PubMed ID: 26715808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An improved strategy to detect the epithelial-mesenchymal transition process in circulating tumor cells in hepatocellular carcinoma patients.
    Liu YK; Hu BS; Li ZL; He X; Li Y; Lu LG
    Hepatol Int; 2016 Jul; 10(4):640-6. PubMed ID: 27115761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial-mesenchymal transitioned circulating tumor cells capture for detecting tumor progression.
    Satelli A; Mitra A; Brownlee Z; Xia X; Bellister S; Overman MJ; Kopetz S; Ellis LM; Meng QH; Li S
    Clin Cancer Res; 2015 Feb; 21(4):899-906. PubMed ID: 25516888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of miR-10b expression in circulating tumor cells.
    Gasch C; Plummer PN; Jovanovic L; McInnes LM; Wescott D; Saunders CM; Schneeweiss A; Wallwiener M; Nelson C; Spring KJ; Riethdorf S; Thompson EW; Pantel K; Mellick AS
    Sci Rep; 2015 Nov; 5():15980. PubMed ID: 26522916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection and clinical significance of circulating tumor cells in peripheral blood of breast cancer patients].
    Cai QQ; Huang HQ; Lin TX; Jiang WQ
    Ai Zheng; 2005 Jul; 24(7):837-41. PubMed ID: 16004811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients.
    Sieuwerts AM; Mostert B; Bolt-de Vries J; Peeters D; de Jongh FE; Stouthard JM; Dirix LY; van Dam PA; Van Galen A; de Weerd V; Kraan J; van der Spoel P; Ramírez-Moreno R; van Deurzen CH; Smid M; Yu JX; Jiang J; Wang Y; Gratama JW; Sleijfer S; Foekens JA; Martens JW
    Clin Cancer Res; 2011 Jun; 17(11):3600-18. PubMed ID: 21505063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of specific detection of circulating tumor cells using combined CD45 staining and fluorescence in situ hybridization.
    Ning N; Zhan T; Zhang Y; Chen Q; Feng F; Yang Z; Liu Z; Xu D; Wang F; Guo Y; Xing J; Guan Y; Cui W
    Clin Chim Acta; 2014 Jun; 433():69-75. PubMed ID: 24607330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicolor detection of rare tumor cells in blood using a novel flow cytometry-based system.
    Watanabe M; Uehara Y; Yamashita N; Fujimura Y; Nishio K; Sawada T; Takeda K; Koizumi F; Koh Y
    Cytometry A; 2014 Mar; 85(3):206-13. PubMed ID: 24327318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic applications of cell-free and circulating tumor cell-associated miRNAs in cancer patients.
    Mostert B; Sieuwerts AM; Martens JW; Sleijfer S
    Expert Rev Mol Diagn; 2011 Apr; 11(3):259-75. PubMed ID: 21463236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enrichment and enumeration of circulating tumor cells by efficient depletion of leukocyte fractions.
    Wu S; Liu Z; Liu S; Lin L; Yang W; Xu J
    Clin Chem Lab Med; 2014 Feb; 52(2):243-51. PubMed ID: 24021598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer.
    Serrano MJ; Ortega FG; Alvarez-Cubero MJ; Nadal R; Sanchez-Rovira P; Salido M; Rodríguez M; García-Puche JL; Delgado-Rodriguez M; Solé F; García MA; Perán M; Rosell R; Marchal JA; Lorente JA
    Oncotarget; 2014 Sep; 5(17):7486-97. PubMed ID: 25277187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis.
    Yokobori T; Iinuma H; Shimamura T; Imoto S; Sugimachi K; Ishii H; Iwatsuki M; Ota D; Ohkuma M; Iwaya T; Nishida N; Kogo R; Sudo T; Tanaka F; Shibata K; Toh H; Sato T; Barnard GF; Fukagawa T; Yamamoto S; Nakanishi H; Sasaki S; Miyano S; Watanabe T; Kuwano H; Mimori K; Pantel K; Mori M
    Cancer Res; 2013 Apr; 73(7):2059-69. PubMed ID: 23378342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146.
    Mostert B; Kraan J; Bolt-de Vries J; van der Spoel P; Sieuwerts AM; Schutte M; Timmermans AM; Foekens R; Martens JW; Gratama JW; Foekens JA; Sleijfer S
    Breast Cancer Res Treat; 2011 May; 127(1):33-41. PubMed ID: 20379845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous phenotypic and genetic characterization of single circulating tumor cells from colon cancer patients.
    Campos M; Luque R; Jiménez J; Martínez R; Warleta F; Sánchez-Quesada C; Delgado-Rodríguez M; Calvo A; Gaforio JJ
    Histol Histopathol; 2013 Nov; 28(11):1439-50. PubMed ID: 23653253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of circulating tumor cells is improved by drug-induced antigen up-regulation: preclinical and clinical studies.
    Bonmassar L; Fossile E; Scoppola A; Graziani G; Prete SP; Formica V; Cappelletti D; De Vecchis L; Cardillo A; Concolino F; D'Atri S; Balduzzi A; Torino F; Caporaso P; Greiner JW; Bonmassar E; Roselli M; Aquino A
    Anticancer Res; 2010 Nov; 30(11):4721-30. PubMed ID: 21115931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD49f-based selection of circulating tumor cells (CTCs) improves detection across breast cancer subtypes.
    Mostert B; Kraan J; Sieuwerts AM; van der Spoel P; Bolt-de Vries J; Prager-van der Smissen WJ; Smid M; Timmermans AM; Martens JW; Gratama JW; Foekens JA; Sleijfer S
    Cancer Lett; 2012 Jun; 319(1):49-55. PubMed ID: 22202642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.